|
|
|
|
|
|
|
|
|
MSDS   | : | 2-Furancarboxylic acid,
tetrahydro-3-hydroxy-2,3,4-trimethyl-5-oxo-,
(2R-(2-alpha,3-beta, 4-alpha))-
| CAS   | : | 26543-09-9 | SYNONYMS   | : | * 2-Furoic acid, tetrahydro-3-hydroxy-2,3,4-trimethyl-5-oxo-, (2R,3R,4R)-
* Monocrotalic acid
|
| |
|
|
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : LU0290000
CHEMICAL NAME : 2-Furancarboxylic acid,
tetrahydro-3-hydroxy-2,3,4-trimethyl-5-oxo-,
(2R-(2-alpha,3-beta, 4-alpha))-
CAS REGISTRY NUMBER : 26543-09-9
LAST UPDATED : 198906
DATA ITEMS CITED : 2
MOLECULAR FORMULA : C8-H12-O5
MOLECULAR WEIGHT : 188.20
WISWESSER LINE NOTATION : T5OVTJ C1 DQ D1 EVQ E1
COMPOUND DESCRIPTOR : Natural Product
SYNONYMS/TRADE NAMES :
* 2-Furoic acid, tetrahydro-3-hydroxy-2,3,4-trimethyl-5-oxo-, (2R,3R,4R)-
* Monocrotalic acid
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 581 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - acute pulmonary edema
Liver - hepatitis (hepatocellular necrosis), diffuse
Blood - lymphoma, including Hodgkin's disease
REFERENCE :
RETOAE Research Today. (Indianapolis, IN) V.1-16, 1944-60. Discontinued.
Volume(issue)/page/year: 5,53,1949
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 606 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - acute pulmonary edema
Liver - hepatitis (hepatocellular necrosis), diffuse
Blood - lymphoma, including Hodgkin's disease
REFERENCE :
RETOAE Research Today. (Indianapolis, IN) V.1-16, 1944-60. Discontinued.
Volume(issue)/page/year: 5,53,1949
*** END OF RECORD ***
|
|
|
|
|
|
|
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
2-Furancarboxylic acid,4,5-dihydro-5-methyl-4-oxo-5-phenyl-
| 72420-38-3 |
2-Furancarboxylic acid,2-(5,6-dihydro-2H-1,4-oxazin-3-yl)hydrazide
| 78205-30-8 |
2-Furancarboxylic acid,2-(3,4-dihydro-2H-pyrrol-5-yl)hydrazide
| 78205-27-3 |
Formamide,N-(8-chloro-2,3,4,5-tetrahydro-1-benzoxepin-5-yl)-
| 37483-68-4 |
2-Furancarboxylic acid,2-(4,5-dihydro-2-thiazolyl)hydrazide
| 78205-25-1 |
2-Furancarboxylic acid,5-((2,3-dioxo-4-((4-(2-pyrimidinylamino)phenyl)methyl)-1-piperazinyl) methyl)-, methyl ester
| 78789-07-8 |
2-Furancarboxylic acid, 3,4-diphenyl-5-nitro-
| 52101-40-3 |
2-Furancarboxylic acid, 3,4-diphenyl-5-nitro-, methylester
| 52101-39-0 |
2-Furancarboxylic acid, 5-methoxy-,6-(aminoiminomethyl)-2-naphthalenyl ester,monomethanesulfonate
| 94084-80-7 |
2-Furancarboxylic acid, 5-nitro-,2-(2H-1,4-benzoxazin-3-yl)hydrazide
| 78959-38-3 |
2-Furancarboxylic acid, 5-nitro-,2-(7-chloro-2H-1,4-benzothiazin-3-yl)hydrazide
| 78959-24-7 |
2-Furancarboxylic acid, 5-nitro-,2-(5,6-dihydro-2H-1,4-oxazin-3-yl)hydrazide
| 78205-31-9 |
2-Furancarboxylic acid, 5-nitro-,2-(3,4-dihydro-2H-pyrrol-5-yl)hydrazide
| 78205-28-4 |
2-Furancarboxylic acid, 5-nitro-,2-(4,5-dihydro-2-thiazolyl)hydrazide
| 78205-26-2 |
Foin absolute
| 8031-00-3 |
Formamide, cyclobutyl-N-(2-fluorenyl)-
| 60550-80-3 |
2-Furancarboxylic acid, 5-nitro-, propyl ester
| 20001-36-9 |
2-Furancarboxylic acid, 7-nitro-8-quinolinyl ester
| 29007-34-9 |
3-Furancarboxylic acid, 5-(phenylmethyl)-
| 24313-22-2 |
2-Furancarboxylic acid,2-(((phenylmethyl)amino)thioxomethyl)hydrazide
| 63224-31-7 |
2-Furancarboxylic acid, 5-(tetradecyloxy)-
| 54857-86-2 |
2-Furancarboxylic acid,tetrahydro-3-hydroxy-2,3,4-trimethyl-5-oxo-,(2R-(2-alpha,3-beta, 4-alpha))-
| 26543-09-9 |
Furan, 2-(chloromethyl)tetrahydro-
| 3003-84-7 |
Furan,4-((2-(4-chlorophenyl)-2-methylpropoxy)methyl)-2-(phenylmethyl)-
| 80843-64-7 |
Furan, 2-(((3-chloropropyl)thio)methyl)-
| 114914-08-8 |
3,4-Furandicarboxylic acid, diethyl ester
| 30614-77-8 |
Formamide, N-cyclohexyl-
| 766-93-8 |
3,3-Furandicarboxylic acid,tetrahydro-4-methylene-5-oxo-, diethyl ester
| 766-93-8 |
Furan, 2,3-dichlorotetrahydro-
| 3511-19-1 |
Furan, 2,5-diethyltetrahydro-
| 41239-48-9 |
2,5-Furandimethanamine,N,N-diethyl-N'-(1-methyl-2-phenylethyl)-,hydrochloride
| 41239-48-9 |
Furan, dimethyl-
| 28802-49-5 |
Furan, 2,5-dimethyl-
| 625-86-5 |
Furan, 2,5-dimethyl-3-thiobenzoyl-
| 101833-03-8 |
Furan, 2,5-dimethyl-3-(thiofuroyl)-
| 101833-04-9 |
Furan, 2,5-dinitro-
| 826-03-9 |
3,4-Furandiol, tetrahydro-2,2-diethyl-5-methyl-
| 31889-35-7 |
Formamide, N-(4-(cyclohexylmethyl)-1-cyclohexyl)-
| 37875-27-7 |
3,4-Furandiol, tetrahydro-2,2,5,5-tetramethyl-
| 29839-67-6 |
2,3-Furandione,4-(1-((4-bromophenyl)imino)ethyl)-5-phenyl-
| 88556-41-6 |
2,3-Furandione,4-(1-((4-chlorophenyl)imino)ethyl)-5-phenyl-
| 88556-40-5 |
2,3-Furandione,4-(1-((4-fluorophenyl)imino)ethyl)-5-methyl-
| 88556-35-8 |
2,3-Furandione,4-(1-((4-fluorophenyl)imino)ethyl)-5-phenyl-
| 88556-39-2 |
2,4(3H,5H)-Furandione,3-((3-hydroxy-2-(hydroxymethyl)-6-(3-hydroxy-2-(tetrahydro-5-methyl-6-(1-methyl-3-(octahydro-5'-(1-hydroxypropyl)-2,4-dimethyl(2,2'-bifuran)-5-yl)-1 -propentyl)-2H-pyran-2-yl)-1-propentyl)-4-methylcyclohexyl)methoxyacetyl)-5-methylene-, monosodium salt,(1R-(1-alpha(2S*),2-beta,3-beta,4-beta,6-beta(E(2R*,5S*,6S*(E(2S*(E(2S*(1' R,5'S*(R*)),4R*, 5S*))))))-
| 120203-60-3 |
2,3-Furandione,4-(1-((4-iodophenyl)imino)ethyl)-5-phenyl-
| 88556-42-7 |
2,3-Furandione,4-(1-((4-methoxyphenyl)imino)ethyl)-5-phenyl-
| 88556-43-8 |
2,3-Furandione,5-methyl-4-(1-((4-methylphenyl)imino)ethyl)-
| 88556-34-7 |
2,3-Furandione, 5-methyl-4-(1-(phenylimino)ethyl)-
| 88556-33-6 |
Formamide,N-((5H-dibenzo(a,d)cyclohepten-5-yl)methyl)-
| 13055-69-1 |
2,3-Furandione,4-(1-((3-methylphenyl)imino)ethyl)-5-phenyl-
| 88556-38-1 |
|
|
|
|